Cocrystal Pharma, Inc. (COCP) vs TScan Therapeutics, Inc. (TCRX)
Cocrystal Pharma, Inc. and TScan Therapeutics, Inc. are both Biotechnology companies. Cocrystal Pharma, Inc. and TScan Therapeutics, Inc. are of similar size ($23.7M and $22.2M). TScan Therapeutics, Inc. grew revenue faster over the last twelve months: 2.15% against −30.4%. Cocrystal Pharma, Inc. has the higher net margin (−747.8% vs −1,655.4%) and the higher return on invested capital (0.00% vs −4,588.2%). Across the 18 metrics below, Cocrystal Pharma, Inc. leads on 9 and TScan Therapeutics, Inc. on 9.
Valuation
Profitability
| Metric | COCP | TCRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 9.10% | 100.00% | 65.16% |
| Operating margin | (760.72%) | (1,695.15%) | 0.00% |
| Net margin | (747.78%) | (1,655.35%) | 0.00% |
| Free cash flow margin | (598.50%) | (1,665.18%) | 0.00% |
| Return on equity | (311.68%) | (95.80%) | (57.72%) |
| Return on assets | (151.10%) | (50.09%) | (49.22%) |
| Return on invested capital | 0.00% | (4,588.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack